Early detection of pancreatic cancer in the era of precision medicine

被引：0

作者：

Ahmed, Taha M. ^{[1
]}

Kawamoto, Satomi ^{[1
]}

Lopez-Ramirez, Felipe ^{[1
]}

Yasrab, Mohammad ^{[1
]}

Hruban, Ralph H. ^{[2
]}

Fishman, Elliot K. ^{[1
]}

Chu, Linda C. ^{[1
]}

机构：

[1] Johns Hopkins Univ Hosp, Russell H Morgan Dept Radiol & Radiol Sci, Baltimore, MD 21287 USA

[2] Johns Hopkins Univ, Sol Goldman Pancreat Canc Res Ctr, Dept Pathol, Sch Med, Baltimore, MD USA

来源：

ABDOMINAL RADIOLOGY | 2024年 / 49卷 / 10期

关键词：

Pancreatic ductal adenocarcinoma; Cancer screening; CT; MRI; Artificial intelligence; Liquid biopsy; CIRCULATING TUMOR-CELLS; METHYLATION-BASED BIOMARKERS; DUCTAL ADENOCARCINOMA; HIGH-RISK; DNA; DIAGNOSIS; CT; PROGRESSION; SIGNATURE; EXOSOMES;

D O I：

10.1007/s00261-024-04358-w

中图分类号：

R8 [特种医学]; R445 [影像诊断学];

学科分类号：

1002 ; 100207 ; 1009 ;

摘要：

Pancreatic ductal adenocarcinoma (PDAC) is the third leading cause of cancer-related mortality and it is often diagnosed at advanced stages due to non-specific clinical presentation. Disease detection at localized disease stage followed by surgical resection remains the only potentially curative treatment. In this era of precision medicine, a multifaceted approach to early detection of PDAC includes targeted screening in high-risk populations, serum biomarkers and "liquid biopsies", and artificial intelligence augmented tumor detection from radiologic examinations. In this review, we will review these emerging techniques in the early detection of PDAC.

引用

页码：3559 / 3573

页数：15

共 50 条

[1] Emerging epigenomic landscapes of pancreatic cancer in the era of precision medicine
Gwen Lomberk
Nelson Dusetti
Juan Iovanna
Raul Urrutia
Nature Communications, 10
[2] Pancreatic Cancer Immuno-oncology in the Era of Precision Medicine
Samarth Hegde
Indian Journal of Surgical Oncology, 2021, 12 : 118 - 127
[3] Pancreatic Cancer Immuno-oncology in the Era of Precision Medicine
Hegde, Samarth
INDIAN JOURNAL OF SURGICAL ONCOLOGY, 2021, 12 (SUPPL 1) : 118 - 127
[4] Emerging epigenomic landscapes of pancreatic cancer in the era of precision medicine
Lomberk, Gwen
Dusetti, Nelson
Iovanna, Juan
Urrutia, Raul
NATURE COMMUNICATIONS, 2019, 10 (1)
[5] Reshaping preoperative treatment of pancreatic cancer in the era of precision medicine
Casolino, R.
Braconi, C.
Malleo, G.
Paiella, S.
Bassi, C.
Milella, M.
Dreyer, S. B.
Froeling, F. E. M.
Chang, D. K.
Biankin, A., V
Golan, T.
ANNALS OF ONCOLOGY, 2021, 32 (02) : 183 - 196
[6] Extracellular vesicles in pancreatic cancer: a new era in precision medicine
Panda, Arunima
Falasca, Marco
Ragunath, Krish
TRANSLATIONAL GASTROENTEROLOGY AND HEPATOLOGY, 2024, 9
[7] Pancreatic ductal adenocarcinoma in the era of precision medicine
Zheng-Lin, Binbin
O'Reilly, Eileen M.
SEMINARS IN ONCOLOGY, 2021, 48 (01) : 19 - 33
[8] Precision Medicine and Pancreatic Cancer
George, Ben
SURGICAL ONCOLOGY CLINICS OF NORTH AMERICA, 2021, 30 (04) : 693 - 708
[9] Cancer Evolution in Precision Medicine Era
Karagiannis, Dimitris
Rampias, Theodoros
CANCERS, 2022, 14 (08)
[10] Gastric Cancer in the Era of Precision Medicine
Liu, Xi
Meltzer, Stephen J.
CELLULAR AND MOLECULAR GASTROENTEROLOGY AND HEPATOLOGY, 2017, 3 (03): : 348 - 358

← 1 2 3 4 5 →